Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

454

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Hypertension
Interventions
DRUG

LCZ696

200 mg tablet

DRUG

Olmesartan

20 mg and 40 mg capsules

DRUG

LCZ696 matching placebo

LCZ696 Matching Placebo tablet

DRUG

Olmesartan matching placebo

Olmesartan matching placebo capsule

DRUG

amlodipine

amlodipine 2.5 mg or 5 mg tablets

DRUG

hydrochlorothiazide

hydrochlorothiazide 6.25mg, 12.5mg, or 25 mg tablets

Trial Locations (47)

112

Novartis Investigative Site, Taipei

114

Novartis Investigative Site, Taipei

10117

Novartis Investigative Site, Berlin

11407

Novartis Investigative Site, Jerez de la Frontera

11525

Novartis Investigative Site, Athens

11526

Novartis Investigative Site, Athens

14215

Novartis Investigative Site, Buffalo

15706

Novartis Investigative Site, A Coruña

21204

Novartis Investigative Site, Baltimore

24047

Novartis Investigative Site, Treviglio

28034

Novartis Investigative Site, Madrid

28041

Novartis Investigative Site, Madrid

33038

Novartis Investigative Site, San Daniele del Friuli

33756

Novartis Investigative Site, Clearwater

39038

Novartis Investigative Site, Belzoni

39209

Novartis Investigative Site, Jackson

40447

Novartis Investigative Site, Taichung

41071

Novartis Investigative Site, Seville

45224

Novartis Investigative Site, Cincinnati

46520

Novartis Investigative Site, Port de Sagunt

54642

Novartis Investigative Site, Thessaloniki

56126

Novartis Investigative Site, Pisa

60607

Novartis Investigative Site, Chicago

63141

Novartis Investigative Site, St Louis

75015

Novartis Investigative Site, Paris

77081

Novartis Investigative Site, Houston

77504

Novartis Investigative Site, Pasadena

77566

Novartis Investigative Site, Lake Jackson

90471

Novartis Investigative Site, Nuremberg

101990

Novartis Investigative Site, Moscow

117198

Novartis Investigative Site, Moscow

119992

Novartis Investigative Site, Moscow

150047

Novartis Investigative Site, Yaroslavl

197022

Novartis Investigative Site, Saint Petersburg

197341

Novartis Investigative Site, Saint Petersburg

C1440AAD

Novartis Investigative Site, Caba

B1704ETD

Novartis Investigative Site, Ramos Mejía

S2000CXH

Novartis Investigative Site, Rosario

Unknown

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Barranquilla

329-0498

Novartis Investigative Site, Shimotsuke

424-717

Novartis Investigative Site, Bucheon-si

110 744

Novartis Investigative Site, Seoul

08003

Novartis Investigative Site, Barcelona

08025

Novartis Investigative Site, Barcelona

08540

Novartis Investigative Site, Centelles

08221

Novartis Investigative Site, Terrassa

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY